Skip to content
Genomics and patient selection in the treatment of mPCa patients episode artwork

EPISODE · Nov 3, 2024 · 9 MIN

Genomics and patient selection in the treatment of mPCa patients

from EAU Podcast · host European Association of Urology

In this interview from UROonco24, Dr. Juan Gómez Rivas (ES) and Dr. Ursula Vogl (CH) discuss advancements in genomic profiling and the use of PARP inhibitors in treating metastatic prostate cancer, with a focus on genomic profiling, patient selection and toxicity management. This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Episode metadata supplied by the publisher feed · Published Nov 3, 2024

Embed this episode

Ready to play

Genomics and patient selection in the treatment of mPCa patients

0:00 9:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of EAU Podcast?

This episode is 9 minutes long.

When was this EAU Podcast episode published?

This episode was published on November 3, 2024.

Can I download this EAU Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!